Goyal R, Jialal I. Diabetes Mellitus Type 2: StatPearls Publishing, Treasure Island (FL); 2022; 2022.

Levey AS. Coresh JJTl. Chronic Kidney Disease. 2012;379(9811):165–80.

Google Scholar 

Poretsky L. Principles of Diabetes Mellitus. Springer; 2010.

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al. Pathophysiology of type 2 Diabetes Mellitus. 2020;21(17):6275.

Cheng AY, Gomes MB, Kalra S, Kengne A-P, Mathieu C, Shaw JEJNRE. Applying the WHO global targets for diabetes mellitus. 2023:1–7.

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 Diabetes Mellitus and its Complications. Nat Rev Endocrinol. 2018;14(2):88–98.

Article  PubMed  Google Scholar 

Ginter E. Simko VJDaod, a new insight. Type 2 diabetes mellitus, pandemic in 21st century. 2013:42–50.

Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G et al. Worldwide trends in Diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants. 2016;387(10027):1513–30.

Atlas DJIDA. Brussels, Belgium: International Diabetes Federation. Int Diabetes Federation. 2015;33:2. 7th ed.

Google Scholar 

Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S et al. Diabetes Mellitus as a risk factor for incident chronic Kidney Disease and end-stage renal Disease in women compared with men: a systematic review and meta-analysis. 2017;55:66–76.

Rasooly RS, Akolkar B, Spain LM, Guill MH, Del Vecchio CT, Carroll LEJCJotASoN. The National Institute of Diabetes and Digestive and kidney Diseases Central repositories: a valuable resource for nephrology research. 2015;10(4):710–5.

Alicic RZ, Rooney MT, Tuttle, KRJCjotASoN. Diabetic Kidney Disease: challenges, progress, and possibilities. 2017;12(12):2032–45.

Heo GY, Koh HB, Kim HW, Park JT, Yoo T-H, Kang S-W, et al. Glycemic control and adverse clinical outcomes in patients with chronic Kidney Disease and type 2 Diabetes Mellitus. Results from KNOW-CKD; 2023.

Chung H, Crowe CL, Kong SX, Singh R, Farej R, Elliott J et al. Descriptive study of the economic burden among patients with type 2 Diabetes Mellitus, chronic Kidney Disease, and chronic Kidney Disease and type 2 Diabetes Mellitus in a large US commercially insured population. 2023;29(1):80–9.

Kainz A, Hronsky M, Stel VS, Jager KJ, Geroldinger A, Dunkler D et al. Prediction of prevalence of chronic Kidney Disease in diabetic patients in countries of the European Union up to 2025. 2015;30(suppl_4):iv113–iv8.

Imtiaz S, Salman B, Qureshi R, Drohlia MF, Ahmad AJSJoKD. Transplantation. A review of the epidemiology of chronic Kidney Disease in Pakistan: a global and regional perspective. 2018;29(6):1441–51.

Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic Kidney Disease and the global NCDs agenda. 2017;2(2):e000380.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic Kidney Disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47.

Article  PubMed  Google Scholar 

Levey AS, Becker C, Inker LAJJ. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic Kidney Disease in adults: a systematic review. 2015;313(8):837–46.

Valmadrid CT, Klein R, Moss SE, Klein BEJA. The risk of Cardiovascular Disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset Diabetes Mellitus. 2000;160(8):1093–100.

Chen W, Chen W, Wang H, Dong X, Liu Q, Mao H et al. Prevalence and risk factors associated with chronic Kidney Disease in an adult population from southern China. 2009;24(4):1205–12.

Chukwuonye II, Ogah OS, Anyabolu EN, Ohagwu KA, Nwabuko OC, Onwuchekwa U et al. Prevalence of chronic kidney disease in Nigeria: systematic review of population-based studies. 2018:165 – 72.

Ephraim RK, Biekpe S, Sakyi SA, Adoba P, Agbodjakey H, Antoh EOJC et al. Prevalence of chronic Kidney Disease among the high risk population in South-Western Ghana; a cross sectional study. 2015;2:76.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. 2003;139(2):137 – 47.

Moosa M, Van der Walt I, Naicker S, Meyers AJSA. Important causes of chronic Kidney Disease in South Africa. 2015;105(4):320–7.

Takamatsu KJC, Nephrology E. Renal status in elderly patients with type 2 Diabetes. 2020;24:53–62.

Wyld ML, Morton RL, Clayton P, Wong MG, Jardine M, Polkinghorne K et al. The impact of Progressive chronic Kidney Disease on health-related quality-of-life: a 12-year community cohort study. 2019;28:2081–90.

Thomas MC, Cooper ME, Zimmet PJNRN. Changing epidemiology of type 2 Diabetes Mellitus and associated chronic Kidney Disease. 2016;12(2):73–81.

Li H, Lu W, Wang A, Jiang H, Lyu JJJ. Changing epidemiology of chronic Kidney Disease as a result of type 2 Diabetes Mellitus from 1990 to 2017: estimates from global burden of Disease 2017. 2021;12(3):346–56.

Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, et al. Epidemiol kidney disease United States. 2017;69(3):A7–A8. US renal data system 2016 annual data report:.

ElHafeez SA, Bolignano D, D’Arrigo G, Dounousi E, Tripepi G, Zoccali C. Prevalence and burden of chronic Kidney Disease among the general population and high-risk groups in Africa: a systematic review. 2018;8(1):e015069.

Skolnik NS, Style AJJDT. Importance of early screening and diagnosis of chronic Kidney Disease in patients with type 2 Diabetes. 2021;12(6):1613–30.

Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine MJ et al. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 Diabetes Mellitus and chronic Kidney Disease: a systematic review and meta-analysis. 2019;21(5):1237–50.

Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RH et al. Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 Diabetes Mellitus: systematic review and meta-analysis of cardiovascular outcomes trials. 2019;139(17):2022–31.

Bikbov B, Purcell C, Levey A, Smith M, Abdoli A, Abebe M et al. GBD chronic Kidney Disease collaboration: global, regional, and national burden of chronic Kidney Disease, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. 2020;395(709–733):32061315.

Schmidt IM, Hübner S, Nadal J, Titze S, Schmid M, Bärthlein B et al. Patterns of medication use and the burden of polypharmacy in patients with chronic Kidney Disease: the German chronic Kidney Disease study. 2019;12(5):663–72.

Alwafi H, Wei L, Naser AY, Mongkhon P, Tse G, Man KK et al. Trends in oral anticoagulant prescribing in individuals with type 2 Diabetes Mellitus: a population-based study in the UK. 2020;10(5):e034573.

Eknoyan G, Lameire N, Eckardt K, Kasiske B, Wheeler D, Levin A et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic Kidney Disease. 2013;3(1):5–14.

Okpara CV, Anselm AU, Felix TO, Omowale A, Gever VCJH. The moderating role of colour in modelling the effectiveness of COVID-19 YouTube animated cartoons on the health behaviour of social media users in Nigeria. 2021;36(6):1599–609.

Masresha SA, Alen GD, Kidie AA, Dessie AA, Dejene TMJSR. First line antiretroviral treatment failure and its association with drug substitution and sex among children in Ethiopia: systematic review and meta-analysis. 2022;12(1):18294.

Higgins J, Green S. Cochrane handbook for systematic reviews of interventions: cochrane book series. Cochrane handbook for systematic reviews of interventions: cochrane book series. 2008. John Wiley & Sons Location: Hoboken, New Jersy, USA; 2008.

Sterne JA, Egger MJJ. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. 2001;54(10):1046–55.

Ahmed MA, Ferede YM, Takele WWJP. Incidence and predictors of chronic Kidney Disease in type-II Diabetes Mellitus patients attending at the Amhara region referral hospitals, Ethiopia: a follow-up study. 2022;17(1):e0263138.

Damtie S, Biadgo B, Baynes HW, Ambachew S, Melak T, Asmelash D et al. Chronic Kidney Disease and associated risk factors assessment among Diabetes Mellitus patients at a tertiary hospital, Northwest Ethiopia. 2018;28(6).

Tannor EK, Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adu‐Gyamfi R, Plange‐Rhule JJTH. Prevalence and predictors of chronic Kidney Disease among Ghanaian patients with Hypertension and Diabetes Mellitus: a multicenter cross‐sectional study. 2019;21(10):1542–50.

Al-Shamsi S, Regmi D, Govender RJP. Chronic Kidney Disease in patients at high risk of Cardiovascular Disease in the United Arab Emirates: a population-based study. 2018;13(6):e0199920.

Sukkar L, Kang A, Hockham C, Young T, Jun M, Foote C et al. Incidence and associations of chronic Kidney Disease in community participants with Diabetes: a 5-year prospective analysis of the EXTEND45 study. 2020;43(5):982–90.

Bramlage P, Lanzinger S, van Mark G, Hess E, Fahrner S, Heyer CH et al. Patient and Disease characteristics of type-2 Diabetes patients with or without chronic Kidney Disease: an analysis of the German DPV and DIVE databases. 2019;18(1):1–12.

González-Pérez A, Saéz ME, Vizcaya D, Lind M, Rodríguez LAGJP. Impact of chronic Kidney Disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 Diabetes in the UK: a cohort study using primary care data from the United Kingdom. 2020;14(4):381–7.

Sim R, Chong CW, Loganadan NK, Adam NL, Hussein Z, Lee SWHJC. Comparison of a chronic Kidney Disease predictive model for type 2 Diabetes Mellitus in Malaysia using Cox regression versus machine learning approach. 2023;16(3):549–59.

Nazzal Z, Hamdan Z, Masri D, Abu-Kaf O, Hamad, MJBn. Prevalence and risk factors of chronic Kidney Disease among Palestinian type 2 diabetic patients: a cross-sectional study. 2020;21:1–8.

Medicine TSGJNEJo. Long-term Complications in youth-onset type 2 Diabetes. 2021;385(5):416–26.

Zhang J, Chen Y, Zou L, Gong RJAD. Prognostic nutritional index as a risk factor for diabetic Kidney Disease and mortality in patients with type 2 Diabetes Mellitus. 2023;60(2):235–45.

McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JF, Marx N et al. Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 Diabetes and established atherosclerotic Cardiovascular Disease and/or chronic Kidney Disease: SOUL, a randomized trial, design and baseline characteristics. 2023.

Duan J, Wang C, Liu D, Qiao Y, Pan S, Jiang D et al. Prevalence and risk factors of chronic Kidney Disease and diabetic Kidney Disease in Chinese rural residents: a cross-sectional survey. 2019;9(1):10408.

Yang L, Chu TK, Lian J, Lo CW, Lau PK, Nan H et al. Risk factors of chronic kidney Diseases in Chinese adults with type 2 Diabetes. 2018;8(1):14686.

Candela JM, González JS, Soidán FJG, Trillo JMM, Espino JD, Bosque DB et al. Chronic renal Disease in Spain: prevalence and related factors in persons with Diabetes Mellitus older than 64 years. 2018;38(4):395–407.

Usó-Talamantes R, González-de-Julián S, Díaz-Carnicero J, Saurí-Ferrer I, Trillo-Mata JL, Carrasco-Pérez M et al. Cost of type 2 Diabetes patients with chronic Kidney Disease based on real-world data: an observational population-based study in Spain. 2021;18(18):9853.

Jitraknatee J, Ruengorn C, Nochaiwong SJS. Prevalence and risk factors of chronic Kidney Disease among type 2 Diabetes patients: a cross-sectional study in primary care practice. 2020;10(1):6205.

Pradidthaprecha A, Muktabhant B, Schelp FP, Tatiyanupanwong S, Thinkhamrop W, Chaichaya N. Renal Disease progression and associated factors in type 2 Diabetes patients: A retrospective cohort study.

Zaman SB, Hossain N, Rahman MJD. journal m. Associations between body mass index and chronic kidney disease in type 2 diabetes mellitus patients: findings from the northeast of Thailand. 2018;42(4):330-7.

Birkeland KI, Bodegard J, Eriksson JW, Norhammar A, Haller H, Linssen GC et al. Heart Failure and chronic Kidney Disease manifestation and mortality risk associations in type 2 Diabetes: a large multinational cohort study. 2020;22(9):1607–18.

Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M et al. Global, regional, and national burden of chronic Kidney Disease, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. 2020;395(10225):709–33.

Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney Diseases. Nephrol Dialysis Transplantation. 2019;34(11):1803–5.

Article  Google Scholar 

Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020;395(10225):709–33.

Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. 2018;94(3):567 – 81.

Carpio EM, Ashworth M, Asgari E, Shaw C, Schartau P, Durbaba S et al. Hypertension and cardiovascular risk factor management in a multi-ethnic cohort of adults with CKD: a cross sectional study in general practice. 2022:1–10.

Fletcher BR, Damery S, Aiyegbusi OL, Anderson N, Calvert M, Cockwell P et al. Symptom burden and health-related quality of life in chronic Kidney Disease: a global systematic review and meta-analysis. 2022;19(4):e1003954.

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023. 2023;11(Supplement1):191–S202.

Google Scholar 

Kohan DE, Barton M. Endothelin and endothelin antagonists in chronic Kidney Disease. Kidney Int. 2014;86(5):896–904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, et al. Change in Albuminuria and GFR as End points for clinical trials in early stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am J Kidney Dis. 2020;75(1):84–104.

Article  CAS  PubMed  Google Scholar 

Cherney DZI, Bell A, Girard L, McFarlane P, Moist L, Nessim SJ, et al. Management of type 2 Diabetic Kidney Disease in 2022: a narrative review for specialists and primary care. Can J Kidney Health Disease. 2023;10:20543581221150556.

Article  Google Scholar 

Li R, Bilik D, Brown MB, Zhang P, Ettner SL, Ackermann RT, et al. Medical costs associated with type 2 Diabetes Complications and comorbidities. Am J Manag Care. 2013;19(5):421–30.

PubMed  PubMed Central  Google Scholar 

International Diabetes Federation. Diabetes Atlas10th edn. https://diabetesatlas.org/en/resources.

Abd ElHafeez S, Bolignano D, D’Arrigo G, Dounousi E, Tripepi G, Zoccali CJB. Prevalence and burden of chronic Kidney Disease among the general population and high-risk groups in Africa: a systematic review. 2018;8(1):e015069.

Naser AY, Alwafi H, Alotaibi B, Salawati E, Samannodi M, Alsairafi Z et al. Prevalence of chronic kidney diseases in patients with diabetes mellitus in the Middle East: A systematic review and meta-analysis. 2021;2021.

Rabieenia E, Jalali R, Mohammadi M. Prevalence of nephropathy in patients with type 2 diabetes in Iran: A systematic review and meta-analysis based on geographic information system (GIS). Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(5):1543-50.

Shrestha N, Gautam S, Mishra SR, Virani SS, Dhungana RRJP. Burden of chronic Kidney Disease in the general population and high-risk groups in South Asia: a systematic review and meta-analysis. 2021;16(10):e0258494.

Jiang W, Wang J, Shen X, Lu W, Wang Y, Li W, et al. Establishment and validation of a risk Prediction Model for Early Diabetic Kidney Disease based on a Systematic Review and Meta-analysis of 20 cohorts. Diabetes Care. 2020;43(4):925–33.

Article  CAS  PubMed  Google Scholar 

Buchan TA, Malik A, Chan C, Chambers J, Suk Y, Zhu JW, et al. Predictive models for cardiovascular and kidney outcomes in patients with type 2 Diabetes: systematic review and meta-analyses. Heart. 2021;107(24):1962–73.

Article  PubMed  Google Scholar 

Wagnew F, Eshetie S, Kibret GD, Zegeye A, Dessie G, Mulugeta H, et al. Diabetic Nephropathy and Hypertension in Diabetes patients of sub-saharan countries: a systematic review and meta-analysis. BMC Res Notes. 2018;11(1):565.

Article  PubMed  PubMed Central  Google Scholar 

Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic Kidney Disease on the African continent: a systematic review and meta-analysis. BMC Nephrol. 2018;19(1):125.

Article  PubMed  PubMed Central  Google Scholar 

Ren Q, Chen D, Liu X, Yang R, Yuan L, Ding M, et al. Derivation and validation of a prediction model of end-stage renal Disease in patients with type 2 Diabetes based on a systematic review and Meta-analysis. Front Endocrinol. 2022;13:825950.

Article  Google Scholar 

Tomino Y, Gohda TJKD. The prevalence and management of diabetic Nephropathy in Asia. 2015;1(1):52–60.

Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L. Conte GJKi. A systematic review and meta-analysis suggests obesity predicts onset of chronic Kidney Disease in the general population. 2017;91(5):1224–35.

Liao X, Shi K, Zhang Y, Huang X, Wang N, Zhang L et al. Contribution of CKD to mortality in middle-aged and elderly people with Diabetes: the China Health and Retirement Longitudinal Study. 2023;15(1):1–8.